Published in Blood Weekly, November 30th, 1998
Benjamin Wizel et al., University of Georgia, evaluated DNA vaccination with the experimental murine model of T. cruzi infection as a way to induce antiparasite protective immunity ("Vaccination with Trypomastigote Surface Antigen 1-Encoding Plasmid DNA Confers Protection against Lethal Trypanosoma cruzi Infection," Infection and Immunity, November 1998;66(11):5073-5081).
As the model antigen, they used the trypomastigote surface antigen 1 (TDA-1), a target of anti-T. cruzi antibody and major...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1998-11-30)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.